West Pharmaceutical Services (WST) Gets a Hold from Barclays
I'm PortAI, I can summarize articles.
Barclays analyst Luke Sergott maintained a Hold rating on West Pharmaceutical Services (WST) with a price target of $325. Sergott has an average return of -2.1% and a 42.02% success rate. West Pharmaceutical Services also received a Hold rating from TR's Jack Scalprey on December 9, but was upgraded to a Buy by Nephron on December 11.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments